Find an expert

Associate Professor Holly Erskine leads the Child and Adolescent Psychiatric Epidemiology and Services (CAPES) research stream at the Queensland Centre for Mental Health Research. She is an Adjunct Associate Professor with the School of Public Health at the University of Queensland and is an affiliate Assistant Professor with the Institute for Health Metrics and Evaluation (IHME) at the University of Washington.

Holly completed her PhD in 2016, examining the global epidemiology of ADHD and conduct disorder as well as the long-term outcomes associated with these disorders, and was awarded the Dean’s Award for Outstanding Higher Degree Theses. For several years, she was responsible for the epidemiological modelling and burden estimation of child and adolescent mental disorders in the Global Burden of Disease Study (GBD) and co-led a programme of work which directly led to the inclusion of bullying victimisation as a risk factor for major depressive disorder and anxiety disorders in GBD. She was awarded an NHMRC Early Career Fellowship in 2018 and was recognised as a Highly Cited Researcher in 2022.

Currently, Holly is the Principal Investigator of the National Adolescent Mental Health Surveys (NAMHS), which involves nationally-representative surveys of the prevalence of adolescent mental disorders in Kenya, Indonesia, and Vietnam. She is also a chief investigator on the Australian Child Maltreatment Study and the Centre for Research Excellence in Adolescent Health Metrics.

David Evans is an NHMRC Leadership Fellow and Professor of Statistical Genetics at the University of Queensland Institute for Molecular Bioscience. He is a winner of the NHMRC Marshall and Warren Award.

He completed his PhD in Statistical Genetics at the University of Queensland in 2003, before undertaking a four-year post-doctoral fellowship at the Wellcome Trust Centre for Human Genetics, University of Oxford where he worked as part of the The International HapMap Consortium and co-led the analysis of four diseases within the first Wellcome Trust Case Control Consortium. In 2007 he moved to take up a Senior Lecturer position at the University of Bristol where he led much of the genome-wide association studies work in the Avon Longitudinal Study of Parents and Children (ALSPAC). In 2013 he returned to take up a chair at the University of Queensland whilst continuing to lead an MRC Programme in statistical genetics at the University of Bristol.

His research interests include the genetic mapping of complex traits and diseases (including birthweight and other perinatal traits, osteoporosis, ankylosing spondylitis, sepsis, laterality) and the development of statistical methodologies in genetic epidemiology including approaches for gene mapping, individual risk prediction, causal modelling and dissecting the genetic architecture of complex traits. He has a particular interest in Mendelian randomization and has used it and other causal methods to investigate the Developmental Origins of Health and Disease (DOHaD)- the idea that adverse intrauterine exposures lead to increased risk of disease in later life.

He is Academic Codirector at the NIH funded International Workshop on Statistical Genetics Methods and is faculty on the European Programme in Educational Epidemiology.

He is Associate Editor at the International Journal of Epidemiology and Behavior Genetics journals.

Dr Alize Ferrari leads the Epidemiology and Burden of Disease Research Stream at the Queensland Centre for Mental Health Research. This stream undertakes a program of work featuring the collection of new epidemiological data for mental disorders, analysis of existing data to quantify the distribution of mental disorders, quantification of the fatal and non-fatal consequences of mental disorders, and the development of methodological frameworks to improve the precision at which we collect and analyse epidemiological data. Dr Ferrari is an Affiliate Professor of Global Health at the Institute for Health Metrics and Evaluation (IHME), University of Washington, and an Honorary Research Fellow at the School of Public Health, University of Queensland. She is the Team Lead for the Mental Disorders Research Team within the Global Burden of Disease (GBD) Study. The GBD initiative is led by IHME and quantifies health loss from over 350 causes. She is the Primary Investigator on the Queensland Urban Indigenous Mental Health Survey. This is a population-based mental health survey of adult Aboriginal and Torres Strait Islanders in Southeast Queensland. It will determine the prevalence of mental and substance use disorders, mental health services being accessed, and implications for service reform.

Professor Jason Ferris, is the Director of Research and Statistical Support Services (RASSS), University of Queensland. While providing service primarily to the Faculty of Medicine the service is expanding to support other organisation units. He is also a leading research academic at the Centre for Health Services Research (CHSR) where he is the Program Leader for Global Substance Use and Mental Health (GSUMH) unit. He holds an honorary professorial role at Turning Point, Victoria (2018-) and is also the Chief Data Scientist for the Global Drug Survey (2013-). Since 2019 he has held a ministerial appointment as an Advisory Council Member to the Queensland Mental Health Commission and is an interRAI Fellow (interrai.org).

Since 2020, Professor Jason Ferris, in collaboration with Dr Dom Gorse (Director of QCIF Data Science) and many others across QCIF and UQ, have been working on the development and deployment of UQ KeyPoint - an innovative data infrastructure, data governance and digital solution enabling researchers to access, manage, analyse and share sensitive research data in a scalable, fully governed and highly secure environment. The work has received a number of accolades. In 2023, The University of Queensland recognised the value of KeyPoint winning the Award for Excellence in Innovation. In 2022, the Faculty of Medicine recognised his commitment and leadership to the University awarding him and the team the Innovators of the Year Award. Professor Ferris has received other recognition as well. In 2021, the Faculty of Medicine recognised the outstanding support of RASSS with a Service Excellence Award. In 2020, The University of Queensland recognised his contributions to his research field: he was awarded the Faculty of Medicine Leader of the Future Award (Academic) and The Director's Choice Award for contributions to the Centre for Health Services Research. In 2019, he was awarded The Outstanding Mid-Career Researcher within the Centre for Health Services Research and was also chosen as a finalist for the Faculty of Medicine Leader of the Future Award (Academic). Additionally, across the Faculty of Medicine, his Research and Statistical Support Service, was nominated for a Service Excellence Award (2019 and 2020). In 2015, he received the University of Queensland, Early Career Researcher Award within the Faculty of Humanities and Social Science. In September, 2014, he received a Highly Commended Early Career Researcher Award within the Faculty of Humanities and Social Science.

He has been involved in a number of key projects: The Queensland Evaluation of the Alcohol Fuelled Violence Policy (QUANTEM), The Overarching Evaluation of the National Support for Child and Youth Mental Health Program (CHYME), the evaluation of ProjectSTOP (a decision-making national database for pharmacists aimed at preventing the use of pseudoephedrine based products as a precursor in the manufacture of methamphetamine), and a national review of the links between random breath testing and alcohol-related road traffic accidents. Jason has over 20 years of social science and public health research experience. He has a well-established publication record with a strong focus on alcohol and drug research and public health. With a Master degree in biostatistics he has well developed and expansive quantitative methods skills and a broad range of experience in many of the facets of both social science and medical research. In 2014 his PhD on alcohol epidemiology was conferred.

Previously, as a senior statistician at the Institute for Social Science Research he developed and taught a number of training models in research methods and statistical analysis as part of the Methods for Social Analysis and Statistics (MFSAS). Since its inception in 2012 he has been course coordinator and trainer for a number of these training modules (see below). From 2016-2018 he was the Director of MFSAS. Between 2016-2017 he was also the ISSR Co-postgraduate Coordinator.

I am a public health sociologist with research interests in the health and wellbeing of people experiencing marginalisation and the social determinants of (sexual) health. I am the course coordinator of PUBH7033 Foundations of Public Health and PUBH7003 Qualitative Research Methods. I am engaged in social research projects related to HIV, sexual health, young people, LGBTIQ+ health, sex worker health and the scholarship of teaching and learning.

Dr Fleming is an occupational therapist and researcher in the field of brain injury rehabilitation. Her PhD completed in 1996 was on the topic of the development of self-awareness following traumatic brain injury. She has continued to pursue collaborative research on role of metacognitive factors in brain injury rehabilitation. Other research interests include prospective memory assessment and rehabilitation, community integration and the transition from hospital to the community, and psychosocial adjustment and outcomes following acquired brain injury, as well as lifetime care and support for people with complex neurological disability. She is Professor of Occupational Therapy at The University of Queensland, and is a Fellow of the Occupational Therapy Australia Research Academy, member of the American Occupational Therapy Research Academy, a Fellow of the Australasian Society for the Study of Brain Impairment, and Co-Editor of Brain Impairment.

Carmel Fleming is a mental health professional with the Queensland Eating Disorder Service (QuEDS) and conjoint Clinical Lecturer with Queensland Health and the School of Nursing, Midwifery and Social Work at the University of Queensland where she teaches in Advanced Practice in Health. At QuEDS Carmel is senior social worker, clinical educator, and clinical supervisor providing consultation and service development across Queensland as well as coordination of QuEDS family and carer services. Prior to this she developed and led the QuEDS statewide education and training program for ten years. Carmel has specialised in mental health and eating disorders since 1992 with a focus on low intensity and specialist interventions such as self help and cognitive behavioural programs as well as family work. Carmel completed her PhD into the effectiveness of services for families of adults affected by eating disorders and maintains a special interest in the clinical support and supervision of other health professionals.

Kitty is an Occupational Therapist and Senior Research Fellow in the Queensland Centre of Excellence in Autism and Intellectual Disability Health. Kitty is leading the Health Services Development team in the National Centre of Excellence in Intellectual Disability Health.

Her research program is focused on improving the health and wellbeing of people with intellectual and developmental disabilities. She completed her PhD at The Kids Institute in Perth, WA. Following this, she undertook a Postdoctoral Research Fellowship at UNSW Sydney which involved co-leading the development of the Australian Longitudinal Study of Autism in Adults (ALSAA). Kitty is passionate about conducting research which is co-developed and co-produced. This includes working with people with intellecutal disability and autistic people in research development and implementation.

Dr Kathryn Fortnum is a Research Fellow at the Health and Wellbeing Centre for Research Innovation, a collaboration between the School of Human Movement and Nutrition Sciences at the University of Queensland, and Health and Wellbeing Queensland. Her research speciality is on the role of physical activity in the management of chronic health conditions. Dr Fortnum is an Accredited Exercise Physiologist and has a particular interest in children and youth, and mental health. Dr Fortnum has worked clinically in inpatient and community settings for the Child and Adolescent Mental Health Service WA, and supported children impacted by neurological disorders including spina bifida and cerebral palsy to engage in community-based physical programs.

Nadine is a physiotherapist, NHMRC Leadership Fellow (leadership level 2) focused on musculoskeletal pain and orthopaedic research, particularly clinical trials, and Academic Director of the University of Queensland's Clinical Trials Centre. Nadine is also the program lead for the Health Research Accelerator (HERA 2) program focused on innovation in clinical trials (ULTRA - UQ's Clinical Trial Capability) and a theme lead for clinical trials in the Centre of Innovation in Pain and Health Research (CIPHeR) at UQ. She is passionate about supporting multidisciplinary groups to work together, with critical mass, to design, conduct, analyse and translate the results of high quality clinical trials, in ways that improve patient and service outcomes.

Nadine is a lifetime Fellow of the Chartered Society of Physiotherapy in the UK, and has held previous National Institute for Health Research (NIHR) Senior Investigator awards and is the only physiotherapist to have held an NIHR Research Professorship in the UK. Having moved to Australia in January 2021, she was the inaugural Director of the STARS Research and Education Alliance between the University of Queensland and Metro North Health in Queensland (STARS is the Surgical, Treatment and Rehabilitation Service, the newest public hospital in Brisbane). Nadine is part of the STARS Alliance multidisciplinary team including conjoint appointments between the University and hospital, across the disciplines of physiotherapy, nursing, occupational therapy, psychology, consumer involvement in research, interdisciplinary collaborative practice in education and practice, and research management.

Nadine's research focuses on musculoskeletal pain, including low back pain, osteoarthritis and shoulder problems, and she has a particular interest in developing, testing and implementing treatments and health services. She has led or collaborated on more than 31 randomised trials, attracting over $145 million in research funding from, for example, the National Institute for Health Research (NIHR), Versus Arthritis, and the Medical Research Council in the UK, PCORI in the USA and the NHMRC and MRFF in Australia. Current examples include international collaborative RCTs funded through the NIHR-NHMRC collaborative trial scheme focused on comparative effectiveness of surgery and conservative care for persistent, severe low back pain and comparative effectiveness of different approaches to shoulder joint replacement for patients with shoulder osteoarthritis. She has supervised 15 PhD students to completion, and 19 Masters research project students (nearly all were healthcare professionals), with 5 PhDs currently in progress in the UK, Europe and Australia. Nadine has led or contributed to over 311 peer reviewed publications, including the Lancet Series on Low Back Pain in 2018.

Examples of recognition as a national and international leader in the field include:

2024 - Elected to the Board of Directors, Australian Clinical Trials Alliance (ACTA)

2024-2029 - NHMRC Investigator Grant, Leadership level 2, supporting a program of research focused on new musculoskeletal RCTs and sharing existing RCT data to answer further research questions

2023 - Stanley Paris Visiting Fellowship award, University of Otago, New Zealand, supporting visiting fellowship in March 2024

2022 - Chief Executive's Award for Research, Metro North Health and Hospital Service Research Excellence Award

2020 - Senior Investigator award from the National Institute for Health Research (NIHR) in the UK, awarded to the top 200 clinical researchers in the country

2019 - PEDro recognition for the UK FASHIoN trial - chosen by a panel of international trialists as one of the five most important physiotherapy trials published in 2014-2019.

2019 - Invited member of the International Research Strategy Advisory Committee for the Health Research Board’s (Ireland) new five year research strategy development

2018 - Miegunyah Distinguished Visiting Fellowship 2019, University of Melbourne, Australia. February-March 2019

Carl (Saibai Koedal) is a PhD Candidate studying the epidemiology of rheumatic heart disease in Queensland using linked hospital and administrative data. Currently, Carl holds an academic appointment (Lecturer, Physiotherapy) in the School of Health and Rehabilitation Sciences, the University of Queensland, and maintains a clinical role as a Staff Physiotherapist at The Prince Charles Hospital. Alongside research, Carl is also working to strengthen relationships between remote Torres Strait Islander communities and UQ to explore opportunities for education, student clinical placement and research partnerships.

Dr Cathy Franklin is passionate about improving the health of people with intellectual disability and those on the autism spectrum. Cathy is a psychiatrist who has specialised in the psychiatry of intellectual disability and autism in adolescents and adults since 2004. Her career focussed on clinical work and education until 2015, when she commenced a part-time research appointment, in addition to her clinical work. Cathy is the inaugural Director of the Mater Intellectual Disability and Autism Service (MIDAS), a state-wide clinical service established in 2018 that works to improve the health and mental health of adults with intellectual disability and those on the autism spectrum. Cathy is also Director of QCIDD, the Queensland Centre for Intellectual and Developmental Disability, a centre established in 1997 by Professor Nick Lennox, and best known for its many contributions to health of people with intellectual disability, including the CHAP health assessment tool and the AbleX massive open-online course that Cathy contributed mental health content to.

Cathy's research interests include health services research and the biological underpinnings and health sequelae of conditions occurring in this population. She is Chief Investigator on several projects, including the EASY-Health (Enhancing Access to Services for Your Health) Project, funded by the Australian Government NDIS ($2.3 million 2020-2024) and the NHMRC funded grant ($1.5M), Bridge to Better Health, investigating whether specialised support to primary care nurses can improve the health of people with intellectual disability attending their practice. Cathy also led MIDAS' successful application as a lead consortium member for the National Centre of Excellence in Intellectual Disability Health ($22.6M over 4 years; consortium led by UNSW). Cathy is a regular presenter at national and internaitonal conferences, often as an invited speaker. She has served on the committee of the RANZCP Section of Psychiatry of Intellectual Disability for over 10 years, is chair of the Qld Branch of the Section and also serves as Vice-President of the Australian Association of Developmental Disability Medicine (AADDM). In 2020 she was awarded the Mater Research Sister Regis Dunne award for Outstanding Contribution to research relative to opportunity.

Dr Alana Gall is a proud Pakana (Tasmanian Aboriginal) woman whose ancestral heritage links to the north-east coast of Lutruwita (Tasmania), and more recently, the Bass Strait Islands of Cape Barren and Flinders Island.

Alana is a Postdoctoral Research Fellow in the First Nations Cancer & Wellbeing Research team, and the Project Manager of the What Matters 2 Adults Implementation project. Alana’s research focusses on wellbeing and holistic health for Indigenous peoples globally. The aim of the WM2A-I study she is managing, is to test the most appropriate and effective methods for implementing the newly developed WM2Adults Wellbeing measure - the first nationally-relevant wellbeing measure developed specifically for Aboriginal and Torres Strait Islander adults.

Alana has a background in nutritional medicine and has more than 10 years’ experience in research, research translation, community engagement, health education and clinical consultation. Alana’s PhD thesis, titled Exploring Wellbeing from Indigenous Perspectives, centres primarily on Aboriginal and Torres Strait Islander peoples’ wellbeing but also includes a focus on the domains of wellbeing for Indigenous peoples in Canada, Aotearoa (New Zealand) and the United States.

On a personal note, Alana is passionate about empowering others to take control of their own health and believes better health and wellbeing can be achieved at a population level through transdisciplinary approaches that adhere to holistic models of health and wellbeing. Alana is also passionate about education, understanding on both an academic and personal level, that this is one significant way to lift individuals, families and communities out of poverty – having hope for the future is imperative to good health and wellbeing. Due to this passion, Alana produced a free worksheet for children during the COVID-19 pandemic, in collaboration with Wingaru Kids about antimicrobial bush medicines and would love to collaborate in this space more.

Marcus Gallagher is an Associate Professor in the Artificial Intelligence Group in the School of Information Technology and Electrical Engineering. His research interests are in artificial intelligence, including optimisation and machine learning. He is particularly interested in understanding the relationship between algorithm performance and problem structure via benchmarking. My work includes cross-disciplinary collaborations and real-world applications of AI techniques.

Dr Gallagher received his BCompSc and GradDipSc from the University of New England, Australia in 1994 and 1995 respectively, and his PhD in 2000 from the University of Queensland, Australia. He also completed a GradCert (Higher Education) in 2010.

Dr Elise Gane graduated with a Bachelor of Physiotherapy (Honours Class I) and a University Medal for academic achievement from The University of Queensland in 2008. She worked as a physiotherapist at the Princess Alexandra Hospital (2009-2013), a quaternary public hospital, treating complex patients across the continuum of care from Intensive Care and post-surgical wards to inpatient rehabilitation and outpatient services. In 2014, Elise commenced her PhD with The University of Queensland, focussed on measuring the musculoskeletal side effects at the neck and shoulder that result from neck dissection surgery for head and neck cancer. Following the awarding of her PhD in early 2018, Elise was employed as a post doctoral researcher at the RECOVER Injury Research Centre (UQ) exploring return to work and social roles after road traffic crash. Since January 2019, Elise has fulfilled the role of Physiotherapy Conjoint Research Fellow between the School of Health and Rehabiltiation Sciences (UQ) and the Princess Alexandra Hospital Physiotherapy Department. In this role, Elise mentors physiotherapists in health service-based research (both qualitative and quantitative) whilst also pursuing her own research interests, including a telehealth cancer exercise program. She teaches a research course in systematic review methodology to students in the Physiotherapy Graduate Entry Masters program.

Elise's areas of research interest include codesign, implementation science, allied health led-models of care, oncology rehabiltiation, lymphoedema, chronic disease, physical activity (particularly in rehabilitation settings, chronic disease, or the workplace), and musculoskeletal health.

Professor Brenda Gannon is an international interdisciplinary leader providing evidence and solutions for health and social care systems, spanning across economics, medicine and social science, in collaboration with academia and industry. She brings extensive experience and expertise in program and policy development related to health, social inclusion, and citizen science, fostering and advancing excellence at the intersection of many disciplines.

Working at the interface of health service delivery, strategic planning and practice influence, and health economics more broadly, across many sectors, enables her research to inform optimisation of health care and workforce organisation. The models are translatable and transferrable across many sectors, including ageing, mental health, child and the working populations.

She is a Professor in the School of Economics and an Affiliate Professor at the Mater Research Institute, The University of Queensland. She is also an affiliate member of CEPAR (ARC Centre for Research Excellence in Population Ageing Research). Since 2022, she is Honorary Adjunct Professor at University of Galway, Ireland. She was Director of Research in the School of Economics from 2018-2023. . She has developed a range of projects on topics of dementia, physical activity and cognition, health and health care utilization, and consumer directed care and home care. She has led and worked extensively on interdisciplinary research with gerontologists,several clinicians and methodologists. Her work has been influential in the development of programs for falls preventions and informing policy on disability and social inclusion, and has positively impacted on the health of many older people across the world. Her work also spans across the lifecyle from birth, and she has worked with clinicians on trials for newborns with breathing difficulities. She is the Health Economics and Epidemiology lead for the Queensland Family Cohort (QFC) Study, the pilot led by Mater Research, and is on the QFC Governance Committee, focusing on maternal mental health, inequalities of opportunity, alcohol use and related health care use and costs.

Professor Gannon’s research carries a dual role, (1) as an applied health economist using big and complex data, utilising health economics theory and concepts to test the validity of causal hypotheses, (2) collaborator across all Faculties leading critical economic evaluations. Her research is funded by her position as chief investigator on projects from the Australian Research Council, National Health and Medical Research Council, MRFF, EU H2020, Health Research Board, Ireland and the National Institute for Health Research, UK. She is the lead economist on projects in dementia, emergency care and paediatric care. All studies incorporate methodological innovations and applied research. She has provided advice to government at senior levels, and had a Ministerial appointment, on the Medical Services Advisory Committee Evaluation Sub-Committee 2017-2021. She sits regularly as a panel member of various NHMRC and MRFF grant review committees and has also previously appointed to the EU Commission grant panels. She has been invited to give several talks at international fora, including a key note talk on ageing and longevity at the National Academy of Medicine, Global Roadmap to Healthy Longevity, in Washington DC. Professor Gannon was an elected Professorial member of the Academic Board at UQ 2018-2022. In 2023, Professor Gannon was elected a Fellow of the Queensland Academy of Arts and Sciences. She has been elected as a Council Member of Queensland Academy of Arts and Sciences since 2024.

Professor Coral Gartner is an international expert in tobacco control policy and the world's leading expert on electronic nicotine delivery systems (or e-cigarettes). She is the Director of the NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame (Tobacco Endgame CRE), an Australian Research Council Future Fellow, and the Chair of the Interdisciplinary Tobacco Endgame Research Network, the country lead Investigator for Australia with the International Tobacco Control Policy Evaluation Project (ITC Project), and a Co-Investigator with the SewAUs Wastewater Epidemiology Project. She is currently the Director of Research at the University of Queensland's School of Public Health, the Regional Editor for Australasia for the BMJ journal, Tobacco Control, after serving as a senior editor from 2012-2018. She is the immediate Past President of the Oceania Chapter of the Society for Research on Nicotine and Tobacco (SRNT-O).

She leads a multidisciplinary research team of international experts (located in Australia, New Zealand, Canada, the USA, England, and the Netherlands) to develop the evidence base for tobacco endgame strategies and to identify the most promising policies that could end the cigarette epidemic in Australia, and beyond. Her research program includes consideration of how these policies could be implemented, while mitigating potential unintended impacts and increasing equity. Her research methods span cohort studies, clinical trials, policy analyses, simulation modelling and mixed methods research.

Professor Gartner joined the University of Queensland in 2006. With undergraduate qualifications in environmental health and a PhD in environmental epidemiology, she completed a postdoctoral fellowship on tobacco control policy and held a NHMRC Career Development Fellowship (2014-2018). In 2019, she led the development of UQ’s flagship cross-faculty postgraduate programs in Environmental Health Sciences.

Professor Gartner has published over 300 academic works, including journal articles, book chapters, and submissions to government inquiries, and has served as an expert witness to a number of government inquiries and consultations. She has also authored articles on tobacco control topics for The Conversation.

Professor Christian Gericke is Clinical Dean and Professor of Medicine at the University of Newcastle, Director of Research and Neurologist at Calvary Mater Newcastle, Honorary Neurologist at the John Hunter Hospital, and Adjunct Professor of Neurology at Fiji National University. He is the Convener of the Specialist Medical Review Council (SMRC), Australian Government, a Member of the Queensland Neurology/Neurosurgery Medical Assessment Tribunal, and regularly acts as an Independent Medical Expert for the Supreme Courts of Queensland, Victoria, New South Wales, South Australia and Western Australia, and the Queensland Coroners Court. He consults privately in Brisbane.

Before this, he was the Clinical Director of Neurology at The Prince Charles Hospital, Professor of Medicine at the University of Queensland, Executive Director of Medical Services, Director of Research and Consultant Neurologist at Cairns Hospital and Adjunct Professor of Medicine and Public Health at James Cook University. He also chaired the Far North Queensland Human Research Ethics Committee (HREC).

From 2013 to 2016, he led the Wesley Research Institute, a non-profit medical research institute based at the Wesley Hospital in Brisbane, as its CEO and Director of Research. In 2016/2017, he spent a sabbatical as Consultant Neurologist with a special interest in Epilepsy at Sheffield Teaching Hospitals NHS Foundation Trust. Since 2013, he has been an Honorary Professor in the School of Public Health at the University of Queensland.

From 2010 to 2012, he was Professor of Public Health and Honorary Consultant Neurologist at Peninsula Medical School, Universities of Exeter and Plymouth and Deputy Director of the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care for the English South West Peninsula (PenCLAHRC).

From 2006 to 2010, he was Professor of Health Policy and Director of the Centre for Health Services Research at the University of Adelaide. He also held various roles for the Australian Commonwealth and State Governments, including as Medical Director for Safety and Quality for the State of Tasmania.

From 2003 to 2006, he was Senior Research Fellow /Associate Professor and Deputy Head of the WHO Collaborating Centre for Health Systems Research and Management at Berlin University of Technology, one of the European Observatory on Health Systems and Policies hubs. He has experience working as a management consultant for McKinsey & Company and as an advisor to the European Commission, WHO, GIZ and the World Bank. His expertise and research interests are in health systems research and health policy, health services research, and the economic evaluation of health interventions. He initiated and directed a new Master's programme in Health Economics and Policy at the University of Adelaide. He is an Editorial Board Member of Frontiers in Neurology, Australian Health Review, Internal Medicine Journal and PLOS ONE.

Prof Gericke studied medicine at the Free University of Berlin and spent one year as a DAAD scholar at Tufts and Harvard Medical Schools in Boston, Massachusetts. He was awarded an M.D. research doctorate (magna cum laude) in cognitive neurology from the Free University of Berlin. After completing clinical specialist training in neurology, epileptology and clinical neurophysiology at the Charite University Hospital in Berlin and the University Hospitals of Strasbourg and Geneva, he studied tropical medicine at the University of Aix-Marseille, obtained an M.P.H. from the University of Cambridge, an M.Sc. in Health Policy, Planning and Financing from the London School of Economics/London School of Hygiene & Tropical Medicine, an MBA from Deakin University, and a higher doctorate (Habilitation) in health systems research from Berlin University of Technology. He also holds an Advanced Diploma in Medical Law from King's Inns School of Law in Dublin and is a Certified Independent Medical Examiner (CIME) with the American Board of Independent Medical Examiners (ABIME).

He is a Fellow of the Royal Australasian College of Physicians (FRACP) in Neurology, the Australasian Faculty of Public Health Medicine (FAFPHM), the Royal College of Physicians of Edinburgh (FRCP Edin), the European Academy of Neurology (FEAN), the American Neurological Association (FANA), the American Academy of Neurology (FAAN) and Associate Fellow of the Royal Australasian College of Medical Administrators (AFRACMA).

He is the Chair of the Australian and New Zealand Association of Neurologists (ANZAN) Therapeutics Committee, Chair of the Ethics Section of the American Academy of Neurology (AAN), and Chair of the Royal Australasian College of Physicians (RACP) Research Committee and a Member of the International League Against Epilepsy (ILAE) Standards and Best Practice Council. He also serves on the Federal Council of the Australian Medical Association (AMA).

Nick joined the School in January 2008. He completed his under-graduate degree (Human Movement Studies) and PhD at Leeds Metropolitan University, UK. His first post-doctoral position was at Liverpool Hope University College, UK where he lectured in Exercise Science (1997-2001). Prior to moving to UQ he was a Senior and Principal Lecturer in Exercise Science and Health within the Carnegie Faculty, Leeds Metropolitan University.

Research Interests:

Nick is an internationally recognised expert in measuring, understanding and influencing occupational physical activity, sedentary behavior, health and productivity. Recent funded work has included leading multi-disciplinary teams in developing and testing innovative health solutions for office workers, truck drivers and veterans. Nick regularly presents to international conferences and academic groups, provides consultancy services to industry, and supervises PhD and other post-graduate projects.